Obermatt
See Similar Stocks →

Equasens

PAR:EQS · FR0012882389
Health Care TechnologySmall

360

40
EV / EBIT57
Price / Owner Earnings19
Owner Earnings Yield63
Dividend Yield81
Price/Sales28
EV / Gross Profit15
Price/Book29
Returns on capital82
EBIT Margin88
Gross Profitability20
Cash Conversion27
Accruals36
Owner Earnings Margin77
Sales growth71
Profit Growth41
Long-Term EPS Growth26
Owner Earnings Growth56
Reinvestment88
Price momentum33
Debt load81
Refinancing31
Debt Payback100
Liquidity92
Analyst ratings73
Opinion Changes7
Price Target Upside55
Market mood69
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Equasens generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryFrance
IndustryHealth Care Technology
SizeSmall
TypePublic Company
ExchangeENXTPA
Founded1996
Employees578
Websiteequasens.com
ISINFR0012882389
Last UpdateApr 2, 2026
Indices
CAC All (France)
Themes
Information Technology

Description

Analysis

Middle-of-the-road

Equasens Société anonyme is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 23.9× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone.

The trajectory is moderate and the balance sheet is sturdy. The company scores 14/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
70
2023202420252026

All-time high

87

Jan 2025

All-time low

23

Jan 2023

Average rank

65

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
28
34
38
38
Price/Earnings
73
67
56
56
Price/Book
29
50
46
38
Dividend Yield
81
84
86
68
Value (overall)
43
65
61
50

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Equasens with its peers
Puig Brands
MCE:PUIG
55
CountrySpain
IndustryPersonal Products
SizeLarge
Full Stock Analysis →
Caesarstone
NSQ:CSTE
22
CountryIsrael
IndustryBuilding Products
SizeSmall
Full Stock Analysis →
Galenica
SWX:GALE
29
CountrySwitzerland
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Bigben Interactive
PAR:BIG
28
CountryFrance
IndustryHousehold Durables
SizeSmall
Full Stock Analysis →
Agfa-Gevaert
BRU:AGFB
29
CountryBelgium
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Cegedim
PAR:ALCGM
65
CountryFrance
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →